Ranked #8,553 of 8,699 institutional investors
BIOS Capital Management, LP
Fort Worth, TX
$22.0M
US stock portfolio at live prices · today +$301K (+1.39%)
Market closed. Prices as of Nov 20, 9:11 AM ET
- Value at quarter end (Q3 2026)
- $34.2M
- Change from Q2 2026
- −$7.5M (−18.00%)
- Positions
- 6 · 0 new, 0 sold out
- Filed
- Nov 13, 2026
Holdings
Q3 2026 13F, live pricesIRD 68.3%CGTX 16.4%ACTU 9.76%RNTX 4.98%LTRN 0.30%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| IRD Opus Genetics, Inc. | 3,683,429 | $15.0M | 68.3% | Unchanged |
| CGTX Cognition Therapeutics, Inc. | 6,000,000 | $3.6M | 16.4% | Unchanged |
| ACTU Actuate Therapeutics, Inc. Common stock | 10,049,996 | $2.1M | 9.76% | Unchanged |
| RNTX Rein Therapeutics Inc. | 2,982,375 | $1.1M | 4.98% | Unchanged |
| LTRN Lantern Pharma Inc. | 235,895 | $67K | 0.30% | Reduced −5% |
| INAB IN8bio, Inc. | 80,957 | $62K | 0.28% | Unchanged |